Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of CEO

20 Sep 2019 07:00

RNS Number : 0394N
Royal Bank of Scotland Group PLC
20 September 2019
 

20 September 2019

RBS appoints Alison Rose as Chief Executive Officer and Executive Director

The Royal Bank of Scotland Group plc (RBS) today announces the appointment of Alison Rose as Executive Director and Chief Executive Officer (CEO).

Alison, currently Deputy CEO NatWest Holdings and CEO Commercial and Private Banking, will take up the position on 1 November 2019 after an orderly handover has taken place. Ross McEwan will formally step down as CEO on 31 October 2019. Alison will also be appointed as Executive Director and CEO on the Boards of NatWest Holdings Limited, The Royal Bank of Scotland plc, National Westminster Bank Plc and Ulster Bank Limited.

RBS Chairman Howard Davies said:

"I am delighted that we have appointed Alison as our new CEO. She brings extensive experience and a track record of success from her previous roles at the bank. Following a rigorous internal and external process, I am confident that we have appointed the best person for the job.

I'd like to take this opportunity to thank Ross, on behalf of the Board, for his leadership and commitment during his time as CEO and wish him the very best for the future. Ross leaves a strong platform for his successor; a bank that has refocussed on its core markets in the UK and Ireland and resolved all its major legacy issues, while returning to profitability and paying dividends."

Alison Rose said:

"It is a huge honour to have been appointed as the new CEO of RBS and I am looking forward to getting started. As one of the oldest and most important financial institutions in the UK, we have a key role to play in supporting the economy and championing the potential that exists across the country.

Under Ross' leadership, RBS has undergone a significant transformation and, as part of his leadership team, I am extremely proud of all we have accomplished, and I would like to thank him for the support he has given me over the last six years. Maintaining the safety and soundness of this bank will continue to underpin everything we do, as will our commitment to our customers and to delivering steady returns for our shareholders.

This is an exciting time as we enter a new chapter for this bank. Our industry is facing a series of challenges; from the ongoing economic and political uncertainty to shifts in the behaviour and expectations of our customers, driven by rapid advances in technology.

It will be my priority to make sure we are ready to meet these challenges and build the best bank for families, businesses and communities. We will be driven with real purpose in our work to help achieve the goals and potential of our customers and be there for them at key moments in their lives."

Alison is also a Non-Executive Director of Great Portland Estates plc and sits on the board of the Coutts Charitable Foundation. There are no other matters to disclose under Listing Rule 9.6.13.

 

Notes to editors

Remuneration arrangements for Alison Rose

Alison Rose's remuneration arrangements have been set in accordance with the Directors' Remuneration Policy approved by shareholders. The remuneration package includes a base salary of £1,100,000 per annum, a fixed share allowance set at 100% of salary and standard benefit funding of £26,250 per annum. Remuneration for Alison has been set at a level that reflects the fact that the current CEO's salary has been unchanged since his appointment in 2013.

Pension funding has been set at 10% of salary. This is in line with the pension rate applicable to the wider RBS workforce and recognises emerging best practice under the UK Corporate Governance Code and investor guidelines.

Variable pay will be delivered entirely in shares as long-term incentive awards, with a maximum award of 175% of salary. Alison will be required to build up and maintain a minimum shareholding equal to 400% of salary.

Alison's remuneration package continues to represent a restrained pay position in terms of comparable roles. Any further increases will be reviewed annually subject to satisfactory performance and development in role.

 

Remuneration arrangements for Ross McEwan

Ross McEwan will continue to receive his fixed remuneration (based on an annual salary of £1,000,000, fixed share allowance of £1,000,000, pension funding of £350,000 and standard benefit funding of £26,250) until his final date of employment on 30 November 2019. No payment will be made in lieu of notice.

The Board determined that Ross meets the test for good leaver retirement and that his forthcoming appointment with National Australia Bank (NAB) will not affect that decision as NAB does not compete directly and materially with RBS given its very limited presence in the UK. Should Ross decide to take on a different role in future, then the criteria would be re-tested.

To meet the criteria for good leaver retirement, the executive director must: be leaving after age 55 or have served more than five years in role; have demonstrated satisfactory performance; not be leaving to work in a capacity considered to be competing directly and materially with RBS; and be leaving at a time and in a manner agreed with the Board.

In line with good leaver status, outstanding LTI awards granted in 2018 and 2019 will continue to vest on their scheduled vesting dates and pro-rating will not apply. The 2017 LTI award was granted under the previous remuneration structure and pro-rating will apply based on Ross' final date of employment. All awards will remain subject to a performance assessment prior to vesting and the potential application of malus and clawback provisions. Any vesting of awards will be disclosed in the Directors' Remuneration Report for the relevant year.

Under the Directors' Remuneration Policy, Ross remains eligible for a further LTI award in respect of performance during 2019, subject to an assessment of his contribution up to his date of departure. Any such award would be disclosed in the 2019 Directors' Remuneration Report.

The above information is provided in compliance with section 430(2B) of the Companies Act 2006.

Alison Rose Biography

 

Alison Rose is currently Deputy CEO of NatWest Holdings and Chief Executive Officer of the Royal Bank of Scotland's Commercial & Private Banking business. As a member of the RBS Executive Management team, she leads over 12,000 people and is accountable for market-leading brands such as Coutts and Lombard.

Alison has worked at RBS for 27 years and, prior to her current role, was Head of Europe, Middle East and Africa, Markets & International Banking.

 

Alison is also a Non-Executive Director of Great Portland Estates plc, having been appointed on 4 April 2018 and sits on the board of the Coutts Charitable Foundation.

 

Alison is a passionate supporter of diversity and is the executive sponsor for the bank's employee-led networks. She was invited by the UK Government to lead a review of the barriers to women starting a business, launched in March 2019, and champions NatWest's Entrepreneur Accelerator programme, an innovative initiative supporting start-up businesses across the UK.

 

 

For further information, please contact:

 

Investor Relations

Alexander Holcroft

Head of Investor Relations

+44 (0) 207 672 1758

 

RBS Media Relations

+44 (0) 131 523 4205

 

 

 

Legal Entity Identifiers

The Royal Bank of Scotland Group plc

2138005O9XJIJN4JPN90

NatWest Holdings Limited

213800GDQMMREYFLQ454

National Westminster Bank Plc

213800IBT39XQ9C4CP71

The Royal Bank of Scotland plc

549300WHU4EIHRP28H10

Ulster Bank Limited

213800BZ9V4RRA2IRN26

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOADDGDCGGBBGCC
Date   Source Headline
17th Mar 20205:24 pmRNSDirectorate Change
17th Mar 20204:42 pmRNSSecond Price Monitoring Extn
17th Mar 20204:38 pmRNSPrice Monitoring Extension
17th Mar 20208:30 amRNSMorgan Stanley European Financials Conference
16th Mar 20205:14 pmRNSNatWest Markets N.V. 2019 ARA
10th Mar 20204:51 pmRNSDirector/PDMR Shareholding
2nd Mar 20202:34 pmRNSDirector/PDMR Shareholding
28th Feb 20204:29 pmRNSCorrection of Dividend Declaration
28th Feb 20201:58 pmRNSTotal Voting Rights and Capital
28th Feb 20207:00 amRNSFiling of Annual Report on Form 20-F with US SEC
27th Feb 20209:55 amRNSBlock Listing Cancellation
24th Feb 202012:40 pmRNSDividend Declaration
20th Feb 20204:10 pmRNSHolding(s) in Company
14th Feb 20203:58 pmRNSRBSG ENTM Publication of Suppl.Prospcts
14th Feb 20207:01 amRNSAnnual Financial Report
14th Feb 20207:00 amRNSFinal Results
31st Jan 20202:12 pmRNSTotal Voting Rights and Capital
30th Jan 20203:57 pmRNSDirector/PDMR Shareholding
16th Jan 20202:08 pmRNSForm 8.3 - Accesso Technology Group plc
2nd Jan 20201:58 pmRNSForm 8.3 - Accesso Technology Group plc
31st Dec 20191:10 pmRNSDirector/PDMR Shareholding
31st Dec 201911:20 amRNSTotal Voting Rights and Capital
30th Dec 20193:02 pmRNSForm 8.3 - Accesso Technology Group plc
20th Dec 20197:00 amRNSPublication of Suppl.Prospcts replacement
19th Dec 20195:40 pmRNSPublication of Suppl.Prospcts
19th Dec 20197:00 amRNSNatWest Markets Change in Executive Directors
16th Dec 20195:47 pmRNS2019 Bank of England stress test results
4th Dec 201912:34 pmRNSForm 8.3 - Accesso Technology Group plc
2nd Dec 20195:34 pmRNSPublication of Suppl.Prospcts
29th Nov 20192:20 pmRNSDirector/PDMR Shareholding
29th Nov 20191:28 pmRNSAnnouncement of NatWest Markets N.V. Transfer
29th Nov 201912:01 pmRNSTotal Voting Rights and Capital
27th Nov 201911:56 amRNSDividend Declaration
21st Nov 20196:26 pmRNSPublication of a Prospectus
21st Nov 201910:45 amRNSReduction in Pillar 2A capital requirements
14th Nov 201911:23 amRNSPublication of Final Terms
13th Nov 20193:00 pmRNSForm 8.3 - Accesso Technology Group plc
8th Nov 20193:00 pmRNSDirector/PDMR Shareholding
1st Nov 20194:12 pmRNSDirector/PDMR Shareholding
31st Oct 20193:30 pmRNSDirector/PDMR Shareholding
31st Oct 20192:08 pmRNSTotal Voting Rights and Capital
30th Oct 20199:38 amRNSRBSG pricing of US$750mn of Subordinated Notes
25th Oct 20195:22 pmRNSPublication of Suppl.Prospcts
24th Oct 20197:00 amRNSQ3 Interim Management Statement
16th Oct 20192:54 pmRNSForm 8.3 - Accesso Technology Group plc
8th Oct 201911:35 amRNSBlock Listing Six Monthly Return
3rd Oct 20191:08 pmRNSPublication of Final Terms
1st Oct 20195:29 pmRNSDirector/PDMR Shareholding
30th Sep 20193:28 pmRNSTotal Voting Rights
24th Sep 20198:30 amRNSBank of America Merrill Lynch Annual Conference

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.